C12N 2501/2315
Interleukin-15
Official title: Interleukin-15 (IL-15)
C12N2501/2315 (Interleukin-15) appears on 324 US grants and 898 published applications in this corpus.
Search patents in C12N- Granted patents
- 324
- Published applications
- 898
- Assignees
- 373
- Inventors
- 1,711
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 4 |
| 2012 | 0 | 4 |
| 2013 | 0 | 11 |
| 2014 | 2 | 15 |
| 2015 | 8 | 12 |
| 2016 | 6 | 14 |
| 2017 | 7 | 28 |
| 2018 | 10 | 38 |
| 2019 | 22 | 56 |
| 2020 | 19 | 56 |
| 2021 | 43 | 117 |
| 2022 | 35 | 120 |
| 2023 | 35 | 103 |
| 2024 | 41 | 108 |
| 2025 | 60 | 124 |
| 2026 | 36 | 83 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Media and methods for differentiating natural killer cells1 Sep 2026US 12,723,233 B2Stemcell Technologies Canada Inc.
- Process for producing donor-batched cells expressing a recombinant receptor11 Aug 2026US 12,703,733 B2Juno Therapeutics, Inc.
- Long lived T cells for treating HIV infection4 Aug 2026US 12,698,318 B2Case Western Reserve University
- Treatment with tumor infiltrating lymphocyte therapies in combination with CTLA-4 and PD-1 inhibitors14 Jul 2026US 12,678,499 B2Iovance Biotherapeutics, Inc.
- Antigen presenting T cells, sensitized, manufactured T cells and methods of treatment using the same14 Jul 2026US 12,680,074 B2Rapa Therapeutics, LLC
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Metabolically enhanced vd1 t cells and uses thereof8 Oct 2026US 2026/0308518 A1
- Methods of enhancing or modifying nk cells8 Oct 2026US 2026/0308525 A1Zelluna Immunotherapy AS
- Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy1 Oct 2026US 2026/0293881 A1Iovance Biotherapeutics, Inc.
- Treatment of autoimmune disorders using chimeric antigen receptor therapy1 Oct 2026US 2026/0295043 A1Novartis AG
Most cited
By later US patents
- Handheld electromechanical surgical system627US 10,932,784 B2Covidien LP · 2021
- Chimeric receptors with 4-1BB stimulatory signaling domain58US 9,856,322 B2St. Jude Children?S Research Hospital · 2018
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy55US 10,130,659 B2Iovance Biotherapeutics, Inc. · 2018
- Method for proliferation of antigen-specific T cells54US 9,476,028 B2Immunicum AB · 2016
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy52US 10,363,273 B2Iovance Biotherapeutics, Inc. · 2019